U.S. Capital Markets Stock News

FDA approves an expanded label for ASCENIV to include pediatric immunodeficiency patients aged two and older. The decision allows earlier intervention for immune compromised children and broadens ASCENIV’s eligible patient pool. The approval fulfills a key post marketing commitment for ADMA Biologics and may influence future commercial uptake. For ADMA Biologics (NasdaqGM:ADMA), this regulatory milestone arrives with the stock trading at $10.08 after a very large 5 year return and a 182.4%...

What is putting Datadog (DDOG) in focus now? Datadog (DDOG) is back on many watchlists after securing FedRAMP High certification and heading into a first quarter earnings report. Options markets expect that report could trigger a meaningful price move. See our latest analysis for Datadog. Datadog’s recent FedRAMP High certification and the upcoming earnings report arrive as the stock trades at US$143.71, with a 30-day share price return of 23.36% and a 1-year total shareholder return of...

In April 2026, Akso Health Group announced it had begun a next-generation Brain-Computer Interface research and development program, building foundational infrastructure to pursue ultra-high-resolution neural sensing, real-time AI neural decoding, and advanced interface design, with related patent applications pending. The company emphasized that it has not yet started human clinical trials, made any regulatory submissions, or generated revenue from BCI activities, underscoring the...

Onto Innovation (ONTO) has opened 2026 with Q1 revenue of US$291.9 million and basic EPS of US$0.68, setting a clear benchmark for how the rest of the year may shape up. The company has seen quarterly revenue move between US$218.2 million and US$291.9 million over the last six reported periods, while basic EPS has ranged from US$0.21 to US$1.30. This gives investors a concrete sense of how top line and per share earnings have tracked through recent cycles. With trailing 12 month net profit...

Mercury Systems (MRCY) has just posted its Q3 2026 numbers, with revenue of US$235.8 million, a basic EPS loss of US$0.05, and net income loss excluding extra items of US$2.9 million shaping the latest snapshot of performance. The company has seen quarterly revenue move from US$211.4 million in Q3 2025 to US$235.8 million in Q3 2026, while basic EPS has shifted from a loss of US$0.33 to a loss of US$0.05 over the same period. This leaves investors weighing top line scale against still...

In April 2026, Enterprise Financial Services Corp reported first-quarter 2026 results with net income of US$49.4 million and diluted EPS of US$1.30, supported by higher net interest income, solid credit metrics, and a tax-equivalent net interest margin of 4.28%. The company also completed a multi-year repurchase of 1,368,517 shares and approved higher common and ongoing preferred dividends, underscoring an increased emphasis on returning capital to shareholders while maintaining a...

Perrigo (PRGO) opened Q1 2026 with revenue of US$969.2 million and a basic EPS loss of US$2.81, while net income excluding extra items came in at a loss of US$389.9 million. Over the past six reported quarters, revenue has ranged between US$969.2 million and US$1.14 billion and basic EPS has moved from a small profit of US$0.09 in Q3 2025 to a loss of US$10.20 in Q4 2025 and US$2.81 in the latest quarter, giving investors a wide view of how the income statement has changed across different...

Investors were disappointed with Waystar Holding Corp.'s ( NASDAQ:WAY ) earnings, despite the strong profit numbers...

Shareholders will be ecstatic, with their stake up 21% over the past week following Axsome Therapeutics, Inc. 's...

Last week, Via Transportation, Inc.'s (NYSE:VIA) stock jumped 12%, but insiders who sold US$29m worth of stock in over...

T-Mobile US, Inc. ( NASDAQ:TMUS ) shareholders (or potential shareholders) will be happy to see that the Chief...

It's been a good week for ADC Therapeutics SA ( NYSE:ADCT ) shareholders, because the company has just released its...

Boise Cascade Company ( NYSE:BCC ) defied analyst predictions to release its quarterly results, which were ahead of...

We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...

Last week saw the newest quarterly earnings release from Hess Midstream LP ( NYSE:HESM ), an important milestone in the...

CoStar Group, Inc. ( NASDAQ:CSGP ) shareholders (or potential shareholders) will be happy to see that the President...

Last week's profit announcement from MediaAlpha, Inc. ( NYSE:MAX ) was underwhelming for investors, despite headline...

As you might know, Labcorp Holdings Inc. ( NYSE:LH ) recently reported its first-quarter numbers. The result was...

The Cheesecake Factory Incorporated ( NASDAQ:CAKE ) shareholders are probably feeling a little disappointed, since its...

We'd be surprised if Bank of Hawaii Corporation ( NYSE:BOH ) shareholders haven't noticed that the Independent...

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...

Key context for Synopsys after recent performance shift Synopsys (SNPS) has drawn fresh attention after a strong recent price move, with the stock up about 27% over the past month and roughly 23% in the past 3 months. That performance sits against an already positive backdrop, with total returns of about 5% over the past year, 36% across 3 years, and 121% over 5 years, prompting closer scrutiny of what investors are currently paying for the stock. See our latest analysis for Synopsys. The...

The Toro Company recently reported past first-quarter fiscal 2026 results that exceeded analyst expectations and raised its full-year guidance, powered by strong professional segment performance and contributions from its Tornado Infrastructure Equipment acquisition. The company also underscored continued investment in innovation and operational excellence, suggesting its professional equipment and infrastructure offerings are becoming increasingly important within its overall business...

What recent performance suggests for BellRing Brands (BRBR) BellRing Brands (BRBR) has seen its stock retreat recently, with a last close of $11.10 and negative returns over the past week, month, past 3 months, year to date, and past year. At the same time, the company reports annual revenue of $2.33b and net income of $158.2m. This reflects its position as a US-focused provider of ready to drink protein shakes, powders, and nutrition bars. See our latest analysis for BellRing...